"STUDYID","STUDYIDN","USUBJID","USUBJIDN","SUBJID","SUBJIDN","SITEID","SITEIDN","ARM","ARMN","ACTARM","ACTARMN","TRT01P","TRT01PN","TRT01A","TRT01AN","TRTSDT","TRTEDT","TRTDURD","AGE","AGEGR1","AGEGR1N","SEX","SEXN","RACE","RACEN","ETHNIC","ETHNICN","PARAMCD","PARAM","PARAMN","PARCAT1","PARCAT2","AVAL","AVALU","AVALC","STARTDT","ADT","CNSR","EVENT","EVNTDESC","SRCDOM","SRCVAR","SRCSEQ","ATPT","ATPTN","AVISIT","AVISITN","DOSE","AUCSS","CMAXSS","CAVGSS","CMINSS","CLSS","AUCSSLOG","AUCSSSTD","AUCSSN","AUCSSDOSE","CMAXSSLOG","CMAXSSSTD","CMAXSSDOSE","CAVGSSLOG","AUCSSCAT","AUCSSCATN","AUCSSQ","AUCSSQN","AUCSSMED","WTBL","WTBLGR1","HTBL","BMIBL","BSABL","CREATBL","CRCLBL","EGFRBL","ALTBL","ASTBL","TBILBL","ALBBL","ANL01FL","ANL02FL","ANL03FL","ANL04FL","ASEQ"
"CDISCPILOT01",1,"01-701-1015",1015,"1015",1015,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-02,2014-07-02,182,63,"<65",1,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",64,"DAYS","CENSORED",2014-01-02,2014-03-06,1,0,"Last Tumor Assessment","ADRS","ADT",9,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.43,"<70 kg",147.32,25.0792713238221,1.49244650006476,79.56,54.7857516339869,71.8538279993146,27,40,10.26,38,"Y","","","",1
"CDISCPILOT01",1,"01-701-1015",1015,"1015",1015,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2014-01-02,2014-07-02,182,63,"<65",1,"F",2,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",182,"DAYS","CENSORED",2014-01-02,2014-07-02,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,54.43,"<70 kg",147.32,25.0792713238221,1.49244650006476,79.56,54.7857516339869,71.8538279993146,27,40,10.26,38,"","Y","","",2
"CDISCPILOT01",1,"01-701-1023",1023,"1023",1023,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-08-05,2012-09-01,28,64,"<65",1,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2012-08-05,2012-08-05,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,80.29,">=70 kg",162.56,30.3832394774165,1.90408496542448,123.76,60.6456787330317,56.1408678383307,23,21,11.97,40,"Y","","","",1
"CDISCPILOT01",1,"01-701-1023",1023,"1023",1023,"701",701,"Placebo",0,"Placebo",0,"Placebo",0,"Placebo",0,2012-08-05,2012-09-01,28,64,"<65",1,"M",1,"WHITE",5,"HISPANIC OR LATINO",1,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",29,"DAYS","CENSORED",2012-08-05,2012-09-02,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,0,0,0,0,0,,-4.60517018598809,,,,-4.60517018598809,,,-4.60517018598809,,,,,,80.29,">=70 kg",162.56,30.3832394774165,1.90408496542448,123.76,60.6456787330317,56.1408678383307,23,21,11.97,40,"","Y","","",2
"CDISCPILOT01",1,"01-701-1028",1028,"1028",1028,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-07-19,2014-01-14,180,71,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",43,"DAYS","EVENT",2013-07-19,2013-08-30,0,1,"Disease Progression","ADRS","ADT",14,"BASELINE",0,"BASELINE",0,81,22.8195487789334,3.78312693625524,0.95081453245556,0.583864543826757,3.5495881528901,3.12805569595451,-0.223393989821081,0.938279971510278,0.281722824431277,1.33319072807224,-0.445357725934204,0.0467052708179659,-0.0399738829606836,"Medium",2,"Q2",2,"Below Median",99.34,">=70 kg",177.8,31.4239403989012,2.21501517426455,123.76,68.1236732385262,53.7492079230433,26,24,18.81,44,"Y","","","",1
"CDISCPILOT01",1,"01-701-1028",1028,"1028",1028,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2013-07-19,2014-01-14,180,71,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",180,"DAYS","CENSORED",2013-07-19,2014-01-14,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,22.8195487789334,3.78312693625524,0.95081453245556,0.583864543826757,3.5495881528901,3.12805569595451,-0.223393989821081,0.938279971510278,0.281722824431277,1.33319072807224,-0.445357725934204,0.0467052708179659,-0.0399738829606836,"Medium",2,"Q2",2,"Below Median",99.34,">=70 kg",177.8,31.4239403989012,2.21501517426455,123.76,68.1236732385262,53.7492079230433,26,24,18.81,44,"","Y","","",2
"CDISCPILOT01",1,"01-701-1033",1033,"1033",1033,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-03-18,2014-03-31,14,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",1,"DAYS","CENSORED",2014-03-18,2014-03-18,1,0,"Randomization","ADSL","RANDDT",,"BASELINE",0,"BASELINE",0,54,15.8320002726693,4.32732373835898,0.659666678027888,0.524224928545608,3.41081348344971,2.76266465825389,-0.949130916709881,0.650970310968839,0.293185190234617,1.46725750775771,-0.205017331149849,0.0801356247844256,-0.400975185869825,"Low",1,"Q1",1,"Below Median",88.45,">=70 kg",175.26,28.7960038217913,2.075100198384,132.6,54.1506108597285,48.5638576919488,16,20,13.68,38,"Y","","","",1
"CDISCPILOT01",1,"01-701-1033",1033,"1033",1033,"701",701,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,"Xanomeline Low Dose",1,2014-03-18,2014-03-31,14,74,"65-75",2,"M",1,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",28,"DAYS","CENSORED",2014-03-18,2014-04-14,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,54,15.8320002726693,4.32732373835898,0.659666678027888,0.524224928545608,3.41081348344971,2.76266465825389,-0.949130916709881,0.650970310968839,0.293185190234617,1.46725750775771,-0.205017331149849,0.0801356247844256,-0.400975185869825,"Low",1,"Q1",1,"Below Median",88.45,">=70 kg",175.26,28.7960038217913,2.075100198384,132.6,54.1506108597285,48.5638576919488,16,20,13.68,38,"","Y","","",2
"CDISCPILOT01",1,"01-701-1034",1034,"1034",1034,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-07-01,2014-12-30,183,77,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"PFS","Progression Free Survival",1,"EFFICACY","TIME TO EVENT",43,"DAYS","CENSORED",2014-07-01,2014-08-12,1,0,"Last Tumor Assessment","ADRS","ADT",9,"BASELINE",0,"BASELINE",0,81,33.6087371196828,4.80892269786072,1.40036404665345,0.82260657599123,2.4100875826293,3.51508356391037,0.897186766508617,1.38190308724528,0.414922680489911,1.57255039641327,0.00767720069401347,0.0593694160229718,0.343847860180925,"High",3,"Q4",4,"Above Median",62.6,"<70 kg",154.94,26.0763757216845,1.64141233224454,88.4,46.3976470588235,58.0399213301922,15,23,10.26,43,"Y","","","",1
"CDISCPILOT01",1,"01-701-1034",1034,"1034",1034,"701",701,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,"Xanomeline High Dose",2,2014-07-01,2014-12-30,183,77,">75",3,"F",2,"WHITE",5,"NOT HISPANIC OR LATINO",2,"OS","Overall Survival",2,"EFFICACY","TIME TO EVENT",183,"DAYS","CENSORED",2014-07-01,2014-12-30,1,0,"Alive","ADSL","LSTALVDT",,"BASELINE",0,"BASELINE",0,81,33.6087371196828,4.80892269786072,1.40036404665345,0.82260657599123,2.4100875826293,3.51508356391037,0.897186766508617,1.38190308724528,0.414922680489911,1.57255039641327,0.00767720069401347,0.0593694160229718,0.343847860180925,"High",3,"Q4",4,"Above Median",62.6,"<70 kg",154.94,26.0763757216845,1.64141233224454,88.4,46.3976470588235,58.0399213301922,15,23,10.26,43,"","Y","","",2
